Call In Line: 855-995-6923
WELCOME TO THE POWER HOUR OFFICIAL WEBSITE. SCHEDULED GUESTS FOR THE BROADCAST THIS WEEK INCLUDE JOHN WHITEHEAD OF THE RUTHERFORD INSTITUTE, DR. BETTY MARTINI ON THE DANGERS OF ASPARTAME, MONETARY EXPERT ANDY GAUSE, CLAY EXPERT PERRY A., JOHN PERKINS ON ECONOMIC HIT MEN, DIRECTOR RICHARD MILNER, MAREE DAY & TONY SAMPSON OF STEM CELL WORX, AND SHARRY EDWARDS ON VOCAL PROFILING. JOIN US LIVE M-F 7- 10 AM CENTRAL TIME (8-11 EST) OR CATCH THE REPLAY 24 HRS A DAY RIGHT HERE @ WWW.POWERHOURNATION.COM




National Vaccine Information Center – The Scripps Research Institute (TSRI) of La Jolla, CA has completed pre-clinical testing of a vaccine to block the “high” effect stimulated by the opioid drug heroin and is now ready to test it in humans following tests that showed the vaccine’s effectiveness in nonhuman primates.  Research on the anti-heroin vaccine was conducted as part of a  study funded by the National Institutes of Health and published in the Journal of the American Chemical Society.  According to TSRI, the vaccine is designed to train the immune system to do something it is not designed to do naturally—recognize a substance (the heroin molecule) that is not a pathogen.3 Since heroin is not a pathogen, the vaccine exposes the immune system to a part of the heroin molecule’s structure forcing the immune system to respond by producing antibodies.

 

ORIGINAL ARTICLE